SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Sangamo Therapeutics, Inc. SGMO
An SI Board Since April 2000
Posts SubjectMarks Bans Symbol
368 43 0 SGMO
Emcee:  Mike McFarland Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
243CANTOR FITZGERALD Company Update FEBRUARY 6, 2008 Sangamo BioSciences Inc. (SGenzyme-2/7/2008
242EQUITY RESEARCH February 6, 2008 Pacific Growth Equities, LLC Sangamo BioScieenzyme-2/7/2008
241Janney Montgomery Scott Sangamo BioSciences (SGMO-$11.87) Sangamo Reports 4Q07enzyme-2/7/2008
240Thanks for posting that.caly-2/5/2008
239Sangamo BioSciences Reports 2007 Fourth Quarter and Year-End Financial Results Senzyme-2/5/2008
238from investorvillage Unfiltered Notes from SGMO 4Q2007 Earnings CC * Liz Wenzyme-2/5/2008
237Sangamo mention in Forbes article from a couple of weeks ago: forbes.com Andy caly-1/23/2008
236Sangamo BioSciences Initiates Phase 2 Clinical Trial of ZFP Therapeutic in Stem sim1-1/7/2008
235Sangamo BioSciences Announces Completion of Enrollment of Phase 2 Clinical Trialsim1-12/4/2007
234Sangamo Partnership Pays Off November 09, 2007: 08:05 PM EST Nov. 12, 2007 (Invsim1-11/11/2007
233Sangamo BioSciences Announces ZFP Therapeutic Data From Nerve Regeneration Progrsim1-11/7/2007
232Sangamo BioSciences Announces Presentation of Phase 1b ZFP Therapeutic Data at Ssim1-11/6/2007
231Sangamo BioSciences Presents Postive Data Showing Pain Reduction by Novel ZFP Thsim1-11/5/2007
230Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonssim1-10/29/2007
229Here's the press release. Sangamo BioSciences Presents Data Demonstrating &sim1-9/19/2007
228Sangamo BioSciences Presents Data Demonstrating 'In Vivo' Protection AgaThe Dodgy Ticker-9/18/2007
227Piper Jaff Jul 30 SGMO report -"Outperform-raise target from $12.50 to $14 bob zagorin-8/20/2007
226xml.10kwizard.combob zagorin-8/10/2007
225excerpt from new TSC (Feurstein) story.. "...Sangamo BioSciences (SGMO) hbob zagorin-8/9/2007
224summary of sgmo investor presentation from IV board.. "...I agree, I thougbob zagorin-8/8/2007
223Piper Jaffray Reiterates Their Outperform Rating on Sangamo BioSciences (SGMO) abob zagorin-7/31/2007
222JMP on SGMO--"Strong quarter of corporate and clinical progress for Sangamobob zagorin-7/25/2007
221full prospectus: xml.10kwizard.combob zagorin-7/18/2007
220Sangamo (SGMO) to sell 3,278,689 shrs @ $9.15 per shr biz.yahoo.com ...proceedMLD38-7/17/2007
219Sangamo BioSciences (SGMO) & Sigma-Aldrich (SIAL) Announce Alliance ...&quoMLD38-7/10/2007
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News